Tag Archives: dxm

Benzo Conversion Tool Updates and Discussion

Around two weeks ago, we released two new web-based harm reduction tools, aimed particularly around helping users make better dosage choices in unclear situations. The first is a benzodiazepine dosage convertor, and the second a DXM dosage calculator. The tools have already proven popular on Facebook and Reddit, being shared relatively widely.

We’ve also been very pleased with the overwhelmingly positive response to these tools online, particularly the constructive feedback that has allowed us to quickly improve upon the quality of our released tools.

One of the major issues arising from formulaic benzodiazepine conversion is that while these drugs share a class, their effect profiles differ quite a bit. They can range between being consciously almost imperceptible at higher doses (sometimes reported with diclazepam), or intensely hypnotic at lower doses (e.g. flunitrazepam).

While benzodiazepines have different effect profiles, most strike some balance between being anxiolytic, hypnotic, and muscle relaxant. Frequently, people will be quick to measure a benzo’s ‘effectiveness’ by its psychoactive or ‘noticeable’ effects, which are most likely to be its hypnotic effects. This will, however, vary depending on your reason for taking it: a highly anxiolytic benzo is likely to feel most ‘effective’ to a person wishing to abort a panic attack, the muscle relaxant for the user experiencing muscle discomfort, etc.

This, and that drug effects of themselves are highly subjective, means there are some immanent limitations on how accurate a benzo dosage conversion can be. However, they remain useful in the case of benzos with similar effect profiles (or at least a similarity where it concerns a sought-after quality), and for tapering use – since we have used standard base equivalencies to diazepam provided by medical texts to derive comparisons.

After discussing these limitations with users, we have revamped the benzo conversion tool to maximise usability and minimise the possibility for misunderstandings.

  • We’ve added a big red notice pointing out that equivalent doses may be inaccurate for larger doses of benzos with different effect profiles.
  • Added drug search and aliases (brand names, generic names, and slang).
  • Inclusion of cards to compare information about the drugs subject to conversion side-by-side, including base dosage, duration, and effect profile information from our API. Using this comparison, you can evaluate differences in the drug’s effect profile, and see its dose ranges when considered as an individual.

Meanwhile, we’ve also added some clarification text to our DXM tool, and some extra information on potential adulterants that certain formulations may contain. We hope that these changes address the primary concerns with our new tools, and allow for maximum usefulness by prospective users with a minimal risk for misleading results.

We’re also working on additional features for this and other tools, which we look forward to telling you about soon!

Update: Just a reminder that we’re still trying to make contact with HR orgs that use our resources! You can do that here.

Facebooktwitterredditpinterest

Recent News and Updates from TripSit

While it has been some time since we’ve written an update on our blog, TripSit itself has by no means been dormant! In this post, I hope to give an overview of a few major updates we’ve been working on, and an idea of what you can expect from us as 2018 continues. We also post more frequent updates on Twitter and Facebook.

Towards the end of the last year, we were invited to present at several harm reduction conferences in Europe, through which we were excited to find that many harm reduction organisations are actively using our resources. We had many productive discussions with these organisations, and hope to work with them more closely in future. To build on this network, we’re currently trying to compile a list of harm reduction organisations using our resources, or who are interested in working with us. In doing this, we can more easily gain feedback and maintain closer relationships with those relying on our services. For this purpose, we’ve placed several adverts around our websites, but if you work for such an organisation, you can let us know about you here.

We have also put a lot of work into improving our online services, publishing two new harm reduction tools and making a major update to our factsheets service.

We’ve created a DXM calculator, inspired by the now defunct tool that used to be available on DarkRidge. This page allows users to easily calculate their DXM doses based on various preparations of DXM-containing medicines, and their weight. Over the coming weeks, we will be expanding this service to include a greater variety of products, and then add harm reduction information concerning dangerous and undesirable additives.

Our other new tool provides a calculator for dosage equivalencies between benzodiazepine drugs. This is possible because the strength of most benzos are measured in terms of their potency in relation to the ‘gold-standard’ of 10mg diazepam. While the base calculator is now finished, work will continue to provide coverage for a greater number of benzodiazepine drugs, and to provide additional advice based on the differing properties of the various drugs in the class: their tendency towards hypnosis, analgesia, anxiolysis, etc.

We’ve also recently rolled out changes to our online chat system, making it easier for people to get help and to improve the general user experience. Most obviously, our web client received a major update, primarily visible through its entirely redesigned user interface. We’d like to thank prawnsalad and the other developers working on Kiwiirc for their stellar software, which helps support what we do.

After being asked many times by willing potential volunteers how to get involved with tripsitting, we decided to streamline the process. Now, when browsing to our chat page, you can see a ‘Here to Help’ button, which will allow you to drop into the support channels in a supporting role.

We have also made a few load-bearing changes to our assistance infrastructure – provisioning more channels, and balancing users between them. These changes were prompted by a large influx of users following coverage of our network from a popular YouTube personality. While these initially presented a challenge for the community both in dealing with the increased load from legitimate users and trolls, it allowed us to develop a more robust and scalable tripsitting service, able to better serve a larger amount of people concurrently as we grow.

In the coming months, we hope to continue developing our existing resources and finding opportunities for realising new ideas. We’re hoping to place a particular focus, this year, on forging relationships with other harm reduction organisations, and investigating how we can all work together to improve continuity of care, and to provide a more cohesive harm reduction infrastructure worldwide.

Facebooktwitterredditpinterest

The Dexterous World of DXM

396px-RomilaradDextromethorphan (DXM) is a dissociative and hallucinogenic drug which is commonly found in cough medicine; its widespread reputation among popular culture and in some sections of drug culture is that it is a drug of convenience, used only by teenagers without access to illicit drugs, taking advantage of their ability to purchase it over the counter in a pharmacy or order it online. However, among some sects, DXM is respected as a powerful and complex psychedelic which can produce experiences wholly different yet similar in worth and intensity as the more traditional hallucinogens. Continue reading The Dexterous World of DXM

Facebooktwitterredditpinterest